Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-…

Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to …

A range of studies globally demonstrate that the effectiveness of SARS-CoV-2 vaccines wane
over time, but the total effect of anti-S antibody levels on risk of SARS-CoV-2 infection and …

Vaccination constitutes the best long-term solution against Coronavirus Disease-2019;
however, vaccine-derived immunity may not protect all groups equally, and the durability of …

Background Understanding the T cell response to SARS-CoV-2 is critical to vaccine
development, epidemiological surveillance and disease control strategies. This systematic review …

Background There is an urgent need to better understand whether individuals who have
recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large …

Vaccines based on the spike glycoprotein of SARS-CoV-2 are being rolled out globally to
control transmission and limit morbidity and mortality due to COVID-19. Current evidence …

Background Progress in characterising the humoral immune response to Severe Acute
Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist. …

The past year has seen the rapid global spread of SARS-CoV-2—the virus responsible for
the ongoing COVID-19 pandemic. While non-pharmaceutical inter ventions have been the …

Background Long-term care facilities (LTCFs) have reported high SARS-CoV-2 infection
rates and related mortality, but the proportion of infected people among those who have …